Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High Grade Cervical Intraepithelial Neoplasia × Vaccines, DNA × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Sexually Transmitted Diseases, Viral 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 High Grade Cervical Intraepithelial Neoplasia 1 Head and Neck Neoplasms 1

Interventions

Vaccines, DNA 1 Vaccines 1 Biological Products 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02529930 2022-07-13

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Nykode Therapeutics ASA

Phase 1/2 Completed

High Grade Cervical Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡